| Griffen Taylor Allan George, MD | |
|
7444 Hannover Pkwy S Ste 210, Stockbridge, GA 30281-7847 | |
| (882) 220-6432 | |
| Not Available |
| Full Name | Griffen Taylor Allan George |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 10 Years |
| Location | 7444 Hannover Pkwy S Ste 210, Stockbridge, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972910339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 82557 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Henry Hospital | Stockbridge, GA | Hospital |
| Piedmont Rockdale Hospital | Conyers, GA | Hospital |
| Southern Regional Medical Center | Riverdale, GA | Hospital |
| Piedmont Fayette Hospital | Fayetteville, GA | Hospital |
| Piedmont Newton Hospital | Covington, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metro Infectious Disease Consultants Llc | 3072425784 | 297 |
News Archive
Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.
Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it will present an abstract demonstrating the utility of its Verisome™ Liquid Drug Delivery System in cystoid macular edema, at the Association for Research in Vision and Ophthalmology (ARVO) 2010 annual meeting, taking place May 2-6, 2010, in Fort Lauderdale, Florida.
The coronavirus disease (COVID-19) is rapidly spreading across the globe, and containment measures have been implemented at many of the hotspots for the disease. Though isolation and quarantine measures are considered the best way to contain the virus, one new study suggests it might not be as effective as hoped.
Studying mice, researchers at Washington University School of Medicine in St. Louis have developed a method of stem cell transplantation that does not require radiation or chemotherapy.
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.
› Verified 8 days ago
| Entity Name | Metro Infectious Disease Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235125717 PECOS PAC ID: 3072425784 Enrollment ID: O20170829003039 |
News Archive
Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.
Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it will present an abstract demonstrating the utility of its Verisome™ Liquid Drug Delivery System in cystoid macular edema, at the Association for Research in Vision and Ophthalmology (ARVO) 2010 annual meeting, taking place May 2-6, 2010, in Fort Lauderdale, Florida.
The coronavirus disease (COVID-19) is rapidly spreading across the globe, and containment measures have been implemented at many of the hotspots for the disease. Though isolation and quarantine measures are considered the best way to contain the virus, one new study suggests it might not be as effective as hoped.
Studying mice, researchers at Washington University School of Medicine in St. Louis have developed a method of stem cell transplantation that does not require radiation or chemotherapy.
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Griffen Taylor Allan George, MD 410 W 10th Ave, Columbus, OH 43210-1240 Ph: (614) 366-5405 | Griffen Taylor Allan George, MD 7444 Hannover Pkwy S Ste 210, Stockbridge, GA 30281-7847 Ph: (882) 220-6432 |
News Archive
Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.
Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it will present an abstract demonstrating the utility of its Verisome™ Liquid Drug Delivery System in cystoid macular edema, at the Association for Research in Vision and Ophthalmology (ARVO) 2010 annual meeting, taking place May 2-6, 2010, in Fort Lauderdale, Florida.
The coronavirus disease (COVID-19) is rapidly spreading across the globe, and containment measures have been implemented at many of the hotspots for the disease. Though isolation and quarantine measures are considered the best way to contain the virus, one new study suggests it might not be as effective as hoped.
Studying mice, researchers at Washington University School of Medicine in St. Louis have developed a method of stem cell transplantation that does not require radiation or chemotherapy.
Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.
› Verified 8 days ago
Dr. Ashar Ul Islam Usmani, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 135 N Park Pl, Stockbridge, GA 30281 Phone: 770-505-1500 | |
Deepa Nankani, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 404-367-3014 | |
Gurinderjit Kaur Sidhu, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1050 Eagles Landing Pkwy Ste 302, Stockbridge, GA 30281 Phone: 770-507-0070 Fax: 770-507-7463 | |
Nizar Ali Tejani, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1004 Hospital Drive, Stockbridge, GA 30281 Phone: 770-507-9929 Fax: 770-507-9930 | |
Dr. Saurabh Singh, M.D Infectious Disease Medicare: May Accept Medicare Assignments Practice Location: 1133 Eagles Landing Pkwy, Stockbridge, GA 30281 Phone: 404-367-3014 | |
Dhruv Chawla, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 350 Country Club Dr Ste A, Stockbridge, GA 30281 Phone: 770-692-4000 | |
Dr. Kyoo Ricard, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3579 Highway 138 Se, Suite 101, Stockbridge, GA 30281 Phone: 770-507-0029 Fax: 770-507-9990 |